Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
Nanosonics Limited ( (AU:NAN) ) has shared an announcement.
UBS Group AG and its related bodies corporate have notified Nanosonics Limited that they have ceased to be a substantial shareholder in the company as of 8 April 2026. The reduction below the substantial holding threshold signals a notable change in the company’s institutional shareholder base, which may alter the balance of major investors and could influence future trading dynamics and governance considerations for stakeholders.
The most recent analyst rating on (AU:NAN) stock is a Buy with a A$4.50 price target. To see the full list of analyst forecasts on Nanosonics Limited stock, see the AU:NAN Stock Forecast page.
More about Nanosonics Limited
Nanosonics Limited is a medical technology company focused on infection prevention solutions for healthcare settings. The company is best known for its ultrasound probe disinfection systems and related products, targeting hospitals and clinics that require high standards of instrument reprocessing and patient safety.
Average Trading Volume: 756,253
Technical Sentiment Signal: Sell
Current Market Cap: A$1.12B
For detailed information about NAN stock, go to TipRanks’ Stock Analysis page.